This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Allen TM. Liposomal drug formulations: rationale for development and what we can expect for the future. Drugs. 1998; 56:747–56.982915010.2165/00003495-199856050-00001AllenTM.Liposomal drug formulations: rationale for development and what we can expect for the futureDrugs.19985674756Search in Google Scholar
Strebhardt K, Ullrich A. Paul Ehrlich’s magic bullet concept: 100 years of progress. Nat Rev Cancer. 2008; 8:473–80.10.1038/nrc239418469827StrebhardtKUllrichA.Paul Ehrlich’s magic bullet concept: 100 years of progressNat Rev Cancer.2008847380Open DOISearch in Google Scholar
Chen X, Huang W, Wong BC, Yin L, Wong YF, Xu M, et al. Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery. Int J Nanomedicine. 2012; 7:1139–48.22412300ChenXHuangWWongBCYinLWongYFXuMLiposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary deliveryInt J Nanomedicine.2012711394810.2147/IJN.S28011Search in Google Scholar
Shek PN, Suntres ZE, Brooks JI. Liposomes in pulmonary applications: physicochemical considerations, pulmonary distribution and antioxidant delivery. J Drug Target. 1994; 2:431–42.770448810.3109/10611869408996819ShekPNSuntresZEBrooksJI.Liposomes in pulmonary applications: physicochemical considerations, pulmonary distribution and antioxidant deliveryJ Drug Target.1994243142Search in Google Scholar
Parthasarathi G, Udupa N, Umadevi P, Pillai G. Niosome encapsulated of vincristine sulfate: improved anticancer activity with reduced toxicity in mice. J Drug Target. 1994; 2:173–82.10.3109/106118694090159078069596ParthasarathiGUdupaNUmadeviPPillaiG.Niosome encapsulated of vincristine sulfate: improved anticancer activity with reduced toxicity in miceJ Drug Target.1994217382Open DOISearch in Google Scholar
Moazeni E, Gilani K, Sotoudegan F, Pardakhty A, Najafabadi AR, Ghalandari R, et al. Formulation and in vitro evaluation of ciprofloxacin containing niosome for pulmonary delivery. J Microencapsul. 2010; 27:618–27.10.3109/02652048.2010.50657920681747MoazeniEGilaniKSotoudeganFPardakhtyANajafabadiARGhalandariRFormulation and in vitro evaluation of ciprofloxacin containing niosome for pulmonary deliveryJ Microencapsul.20102761827Open DOISearch in Google Scholar
Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharm Sin B. 2011; 1:208–19.10.1016/j.apsb.2011.09.002KumarGPRajeshwarraoP.Nonionic surfactant vesicular systems for effective drug delivery—an overviewActa Pharm Sin B.2011120819Open DOISearch in Google Scholar
Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998; 172:33–70.10.1016/S0378-5173(98)00169-0UchegbuIFVyasSP.Non-ionic surfactant based vesicles (niosomes) in drug deliveryInt J Pharm.19981723370Open DOISearch in Google Scholar
Rangasamy M, Ayyasamy B, Raju S, Gummadevelly S, Shaik S. Formulation and in vitro evaluation of niosome encapsulated acyclovir. J Pharm Res. 2008; 1:163–6.RangasamyMAyyasamyBRajuSGummadevellySShaikS.Formulation and in vitro evaluation of niosome encapsulated acyclovirJ Pharm Res.200811636Search in Google Scholar
Bhaskaran S, Lakshmi PK. Comparative evaluation of niosome formulations prepared by different techniques. Acta Pharma Sci. 2009; 51:27–32.BhaskaranSLakshmiPK.Comparative evaluation of niosome formulations prepared by different techniquesActa Pharma Sci.2009512732Search in Google Scholar
Negi LM, Garg AK, Chauhan M. Ultradeformable vesicles: concept and execution. Pharma Times. 2009; 41:11–4.NegiLMGargAKChauhanM.Ultradeformable vesicles: concept and executionPharma Times.200941114Search in Google Scholar
Sankar V, Ruckmani K, Jailani S, Ganesan KS, Sharavanan SP. Niosome drug delivery system: advances and medical applications – an overview. Pharmacologyonline. 2009; 2:926–32.SankarVRuckmaniKJailaniSGanesanKSSharavananSP.Niosome drug delivery system: advances and medical applications – an overviewPharmacologyonline.2009292632Search in Google Scholar
Uchegbu IF, Florence AT. Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Colloid Interface Sci. 1995; 58:1–55.10.1016/0001-8686(95)00242-IUchegbuIFFlorenceAT.Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistryAdv Colloid Interface Sci.199558155Open DOISearch in Google Scholar
Bouwstra JA, van Hal DA, Hofland HEJ, Junginger HE. Preparation and characterization of nonionic surfactant vesicles. Colloids Surf A: Physicochem Eng Aspects. 1997; 123–124:71–80.BouwstraJAvan HalDAHoflandHEJJungingerHE.Preparation and characterization of nonionic surfactant vesiclesColloids Surf A: Physicochem Eng Aspects.1997123124718010.1016/S0927-7757(96)03800-9Search in Google Scholar
Baillie AJ, Florence AT, Hume LR, Muirhead GT, Rogerson A. The preparation and properties of niosomes—non-ionic surfactant vesicles. J Pharm Pharmacol. 1985; 37:863–68.286809210.1111/j.2042-7158.1985.tb04990.xBaillieAJFlorenceATHumeLRMuirheadGTRogersonA.The preparation and properties of niosomes—non-ionic surfactant vesiclesJ Pharm Pharmacol.19853786368Search in Google Scholar
Tiwari G, Tiwari R, Sriwastawa B, Bhati L, Pandey S, Pandey P, et al. Drug delivery systems: an updated review. Int J Pharma Investig. 2012; 2:2–11.10.4103/2230-973X.96920TiwariGTiwariRSriwastawaBBhatiLPandeySPandeyPDrug delivery systems: an updated reviewInt J Pharma Investig.20122211Open DOISearch in Google Scholar
Thacharodi D, Rao KP. Development and in vitro evaluation of chitosan-based transdermal drug delivery system for the controlled delivery of propranolol hydrochloride. Biomaterials. 1995; 16:145–8.10.1016/0142-9612(95)98278-MThacharodiDRaoKP.Development and in vitro evaluation of chitosan-based transdermal drug delivery system for the controlled delivery of propranolol hydrochlorideBiomaterials.1995161458Open DOISearch in Google Scholar
Krishna R, Pandit JK. Carboxymethylcellulose-sodium based transdermal drug delivery system for propranolol. J Pharm Pharmacol. 1996; 48:367–70.10.1111/j.2042-7158.1996.tb05934.x8794984KrishnaRPanditJK.Carboxymethylcellulose-sodium based transdermal drug delivery system for propranololJ Pharm Pharmacol.199648367708794984Open DOISearch in Google Scholar
Bhat M, Shenoy DS, Udupa N, Srinivas CR. Optimization of delivery of betamethasone-dipropionate from skin preparation. Indian Drugs. 1995; 32:211–4.BhatMShenoyDSUdupaNSrinivasCR.Optimization of delivery of betamethasone-dipropionate from skin preparationIndian Drugs.1995322114Search in Google Scholar
Diljyot K. Niosomes: a new approach to targeted drug delivery. Int J Pharm Phytopharm Res. 2012; 2:53–9.DiljyotK.Niosomes: a new approach to targeted drug deliveryInt J Pharm Phytopharm Res.20122539Search in Google Scholar
Malhotra M, Jain NK. Niosomes as drug carriers. Indian Drugs. 1994; 31:81–6.MalhotraMJainNK.Niosomes as drug carriersIndian Drugs.199431816Search in Google Scholar
Giddi HS, Arunagirinathan MA, Bellare JR. Self-assembled surfactant nano-structures important in drug delivery: a review. Indian J Exp Biol. 2007; 45:133–59.17375554GiddiHSArunagirinathanMABellareJR.Self-assembled surfactant nano-structures important in drug delivery: a reviewIndian J Exp Biol.20074513359Search in Google Scholar
Biju SS, Talegaonkar S, Mishra PR, Khar RK. Vesicular systems: an overview. Indian J Pharm Sci. 2006; 68:141–53.10.4103/0250-474X.25707BijuSSTalegaonkarSMishraPRKharRK.Vesicular systems: an overviewIndian J Pharm Sci.20066814153Open DOISearch in Google Scholar
Bandyopadhyay P, Johnson M. Fatty alcohols or fatty acids as niosomal hybrid carrier: effect on vesicle size, encapsulation efficiency and in vitro dye release. Colloids Surf B Biointerfaces. 2007; 58:68–71.10.1016/j.colsurfb.2007.01.01417339104BandyopadhyayPJohnsonM.Fatty alcohols or fatty acids as niosomal hybrid carrier: effect on vesicle size, encapsulation efficiency and in vitro dye releaseColloids Surf B Biointerfaces.200758687117339104Open DOISearch in Google Scholar
Shan W, Liu H, Shi J, Yang L, Hu N. Self-assembly of electroactive layer-by-layer films of heme proteins with anionic surfactant dihexadecyl phosphate. Biophys Chem. 2008; 134:101–9.1829475210.1016/j.bpc.2008.01.008ShanWLiuHShiJYangLHuN.Self-assembly of electroactive layer-by-layer films of heme proteins with anionic surfactant dihexadecyl phosphateBiophys Chem.2008134101918294752Search in Google Scholar
Gandhi A, Sen SO, Paul A. Current trend in niosome as vesicular drug delivery system. Asian J Pharm Life Sci. 2012; 2:339–53.GandhiASenSOPaulA.Current trend in niosome as vesicular drug delivery systemAsian J Pharm Life Sci.2012233953Search in Google Scholar
Kazi KM, Mandal AS, Biswas N, Guha A, Chatterjee SA, Behera M, et al. Niosome: a future of targeted drug delivery systems. J Adv Pharm Tech Res. 2010; 1:374–80.10.4103/0110-5558.76435KaziKMMandalASBiswasNGuhaAChatterjeeSABeheraMNiosome: a future of targeted drug delivery systemsJ Adv Pharm Tech Res.2010137480325540422247876Open DOISearch in Google Scholar
Sahin NO. Niosomes as nanocarrier systems. In: Mozafari MR, editor. Nanomaterials and nanosystems for biomedical applications. Dordrecht: Springer; 2007. p. 67–82.SahinNO.Niosomes as nanocarrier systemsMozafariMRNanomaterials and nanosystems for biomedical applicationsDordrechtSpringer2007678210.1007/978-1-4020-6289-6_4Search in Google Scholar
Keservani RK, Sharma AK, Ayaz Md, Kesharwani RK. Novel drug delivery system for the vesicular delivery of drug by the niosomes. Int J Res Controlled Release. 2011; 1:1–8.KeservaniRKSharmaAKAyazMdKesharwaniRK.Novel drug delivery system for the vesicular delivery of drug by the niosomesInt J Res Controlled Release.2011118Search in Google Scholar
Khandare JN, Madhavi G, Tamhankar BM. Niosomes novel drug delivery system. The Eastern Pharmacist. 1994; 37:61–4.KhandareJNMadhaviGTamhankarBM.Niosomes novel drug delivery systemThe Eastern Pharmacist.199437614Search in Google Scholar
Jayaraman SC, Ramachandran C, Weiner N. Topical delivery of erythromycin from various formulations: an in vivo hairless mouse study. J Pharm Sci. 1996; 85:1082–84.10.1021/js960040uJayaramanSCRamachandranCWeinerN.Topical delivery of erythromycin from various formulations: an in vivo hairless mouse studyJ Pharm Sci.1996851082848897275Open DOISearch in Google Scholar
Raja NRA, Pillai GK, Udupa N, Chandrashekhar G. Anti-inflammatory activity of niosome encapsulated diclofenac sodium in arthritic rats. Indian J Pharmacol. 1994; 26:46–8.RajaNRAPillaiGKUdupaNChandrashekharG.Anti-inflammatory activity of niosome encapsulated diclofenac sodium in arthritic ratsIndian J Pharmacol.199426468Search in Google Scholar
Chauhan S, Luorence MJ. The preparation of polyoxyethylene containing non-ionic surfactant vesicles. Cox B, editor. British Pharmaceutical Conference 1989, Science Proceedings 126th Meeting; 1989 September 11–14; Keele, United Kingdom. London: Royal Pharmacological Society of Great Britain. J Pharm Pharmacol. 1989; 41 Suppl:6P.ChauhanSLuorenceMJ.The preparation of polyoxyethylene containing non-ionic surfactant vesiclesCoxBBritish Pharmaceutical Conference 1989, Science Proceedings 126th Meeting; 1989 September 11–14; KeeleUnited Kingdom. LondonRoyal Pharmacological Society of Great Britain. J Pharm Pharmacol1989416Search in Google Scholar
Mayer LD, Bally MB, Hope MJ, Cullis PR. Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochim Biophys Acta. 1985; 816:294–302.10.1016/0005-2736(85)90497-33839135MayerLDBallyMBHopeMJCullisPR.Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potentialBiochim Biophys Acta.1985816294302Open DOISearch in Google Scholar
Verma AK, Bindal JC. A vital role of niosomes on controlled and novel drug delivery. Indian J Novel Drug Deliver. 2011; 3:238–46.VermaAKBindalJC.A vital role of niosomes on controlled and novel drug deliveryIndian J Novel Drug Deliver.2011323846Search in Google Scholar
Aggarwal D, Garg A, Kaur IP. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation. J Pharm Pharmacol. 2004; 56:1509–17.10.1211/002235704489615563757AggarwalDGargAKaurIP.Development of a topical niosomal preparation of acetazolamide: preparation and evaluationJ Pharm Pharmacol.200456150917Open DOISearch in Google Scholar
Hao Y, Zhao F, Li N, Yang Y, Li K. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm. 2002; 244:73–80.10.1016/S0378-5173(02)00301-012204566HaoYZhaoFLiNYangYLiK.Studies on a high encapsulation of colchicine by a niosome systemInt J Pharm.20022447380Open DOISearch in Google Scholar
Sankhyan A, Pawar P. Recent trends in niosome as vesicular drug delivery system. J Appl Pham Sci. 2012; 2:20–32.SankhyanAPawarP.Recent trends in niosome as vesicular drug delivery systemJ Appl Pham Sci.201222032Search in Google Scholar
Udupa N. Niosomes as drug carriers. In: Jain NK, editor, Controlled and novel drug delivery. New Delhi: CBS Publishers and Distributors; 2002. p. 292–303.UdupaN.Niosomes as drug carriersJainNKControlled and novel drug deliveryNew DelhiCBS Publishers and Distributors2002292303Search in Google Scholar
Muzzalupo R, Tavano L, Lai F, Picci N. Niosomes containing hydroxyl additives as percutaneous penetration enhancers: effect on the transdermal delivery of sulfadiazine sodium salt. Colloids Surf B Biointerfaces. 2014; 123:207–12.2526022010.1016/j.colsurfb.2014.09.017MuzzalupoRTavanoLLaiFPicciN.Niosomes containing hydroxyl additives as percutaneous penetration enhancers: effect on the transdermal delivery of sulfadiazine sodium saltColloids Surf B Biointerfaces.201412320712Search in Google Scholar
Rogerson A, Cummings J, Florence AT. Adriamycin-loaded niosomes: drug entrapment, stability and release. J Microencapsul. 1987; 4:321–8.350451310.3109/02652048709021824RogersonACummingsJFlorenceAT.Adriamycin-loaded niosomes: drug entrapment, stability and releaseJ Microencapsul.198743218Search in Google Scholar
Arunothayanun P, Bernard M-S, Craig DQM, Uchegbu IF, Florence AT. The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from hexadecyl diglycerol ether. Int J Pharm. 2000; 201:7–14.1086726010.1016/S0378-5173(00)00362-8ArunothayanunPBernardM-SCraigDQMUchegbuIFFlorenceAT.The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from hexadecyl diglycerol etherInt J Pharm.2000201714Search in Google Scholar
Biswal S, Murthy PN, Sahu J, Sahoo P, Amir F. Vesicles of non-ionic surfactants (niosomes) and drug delivery potential. Int J Pharm Sci Nanotech. 2008; 1:1–8.BiswalSMurthyPNSahuJSahooPAmirF.Vesicles of non-ionic surfactants (niosomes) and drug delivery potentialInt J Pharm Sci Nanotech.200811810.37285/ijpsn.2008.1.1.1Search in Google Scholar
Hu C, Rhodes DG. Proniosomes: a novel drug carrier preparation. Int J Pharm. 1999; 185:23–5.1042536210.1016/S0378-5173(99)00122-2HuCRhodesDG.Proniosomes: a novel drug carrier preparationInt J Pharm.1999185235Search in Google Scholar
Solanki AB, Parikh JR, Parikh RH. Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken design. AAPS PhamSciTech. 2007; 8:43. 10.1208/pt0804086.SolankiABParikhJRParikhRH.Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken designAAPS PhamSciTech.200784310.1208/pt0804086275037718181547Open DOISearch in Google Scholar
Ibrahim MMA, Sammour OA, Hammad MA, Megrab NA. In vitro evaluation of proniosomes as a drug carrier for flurbiprofen. AAPS PhamSciTech. 2008; 9:782–90.10.1208/s12249-008-9114-0IbrahimMMASammourOAHammadMAMegrabNA.In vitro evaluation of proniosomes as a drug carrier for flurbiprofenAAPS PhamSciTech.2008978290297703518587650Open DOISearch in Google Scholar
Reddy BS, Padman JSC, Santosh V. Niosomes as nanocarrier systems: a review. Int J Pharm Sci Res. 2012; 3:1560–68.ReddyBSPadmanJSCSantoshV.Niosomes as nanocarrier systems: a reviewInt J Pharm Sci Res.20123156068Search in Google Scholar
Zasadzinski JA, Wong B, Forbes N, Gary B, Wu G. Novel methods of enhanced retention in and rapid, targeted release from liposomes. Curr Opin Colloid Interface Sci. 2011; 16:203–14.10.1016/j.cocis.2010.12.00421603081ZasadzinskiJAWongBForbesNGaryBWuG.Novel methods of enhanced retention in and rapid, targeted release from liposomesCurr Opin Colloid Interface Sci.20111620314Open DOISearch in Google Scholar
Yoo J-W, Doshi N, Mitragotri S. Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. Adv Drug Deliv Rev. 2011; 63:1247–56.10.1016/j.addr.2011.05.00421605607YooJ-WDoshiNMitragotriS.Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug deliveryAdv Drug Deliv Rev.201163124756Open DOISearch in Google Scholar
Chakraborty S, Shukla D, Mishra B, Singh S. Lipid – An emerging platform for oral delivery of drugs with poor bioavailability. Eur J Pharm Biopharm. 2009; 73:1–15.10.1016/j.ejpb.2009.06.00119505572ChakrabortySShuklaDMishraBSinghS.Lipid – An emerging platform for oral delivery of drugs with poor bioavailabilityEur J Pharm Biopharm.200973115Open DOISearch in Google Scholar
Rajera R, Nagpal K, Singh SK, Mishra DN. Niosomes: a controlled and novel drug delivery system. Biol Pharm Bull. 2011; 34:945–53.2171999610.1248/bpb.34.945RajeraRNagpalKSinghSKMishraDN.Niosomes: a controlled and novel drug delivery systemBiol Pharm Bull.20113494553Search in Google Scholar
Mujoriya RZ, Dhamande K, Bodla RB. Niosomal drug delivery system – a review. Int J Appl Pharm. 2011; 3:7–10.MujoriyaRZDhamandeKBodlaRB.Niosomal drug delivery system – a reviewInt J Appl Pharm.20113710Search in Google Scholar
Medda S, Mukhopadhyay S, Basu MK. Evaluation of the in-vivo activity and toxicity of amarogentin, an antileishmanial agent, in both liposomal and niosomal forms. J Antimicrob Chemother. 1999; 44:791–4.10.1093/jac/44.6.79110590280MeddaSMukhopadhyaySBasuMK.Evaluation of the in-vivo activity and toxicity of amarogentin, an antileishmanial agent, in both liposomal and niosomal formsJ Antimicrob Chemother.1999447914Open DOISearch in Google Scholar
Kieburtz KD, Seidlin M, Lambert JS, Dolin R, Reichman R, Valentine F. Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine. J Acquir Immune Defic Syndr. 1992; 5:60–4.1346633KieburtzKDSeidlinMLambertJSDolinRReichmanRValentineF.Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosineJ Acquir Immune Defic Syndr.19925604Search in Google Scholar
Devaraj GN, Parakh SR, Devraj R, Apte SS, Rao RB, Rambhau D. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. J Colloid Interface Sci. 2002; 251:360–65.1629074110.1006/jcis.2002.8399DevarajGNParakhSRDevrajRApteSSRaoRBRambhauD.Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterolJ Colloid Interface Sci.200225136065Search in Google Scholar
Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. AAPS PhamSciTech. 2010; 11:1119–27.10.1208/s12249-010-9480-2RuckmaniKSankarV.Formulation and optimization of zidovudine niosomesAAPS PhamSciTech.201011111927Open DOISearch in Google Scholar
Cummings J, Stuart JFB, Calman KC. Determination of adriamycin, adriamycinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatography. J Chromatogr B Biomed Appl. 1984; 311:125–33.10.1016/S0378-4347(00)84698-8CummingsJStuartJFBCalmanKC.Determination of adriamycin, adriamycinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatographyJ Chromatogr B Biomed Appl.198431112533Open DOISearch in Google Scholar
Udupa N, Chandraprakash KS, Umadevi P, Pillai GK. Formulation and evaluation of methotrexate niosomes. Drug Dev Indust Pharm. 1993; 19:1331–42.10.3109/03639049309074404UdupaNChandraprakashKSUmadeviPPillaiGK.Formulation and evaluation of methotrexate niosomesDrug Dev Indust Pharm.199319133142Open DOISearch in Google Scholar
Paolino D, Cosco D, Muzzalupo R, Trapasso E, Picci N, Fresta M. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm. 2008; 353:233–42.1819150910.1016/j.ijpharm.2007.11.037PaolinoDCoscoDMuzzalupoRTrapassoEPicciNFrestaM.Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancerInt J Pharm.20083532334218191509Search in Google Scholar
Nesaretnam K, Guthrie N, Chambers AF, Carroll KK. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids. 1995; 30:1139–43.10.1007/BF025366158614304NesaretnamKGuthrieNChambersAFCarrollKK.Effect of tocotrienols on the growth of a human breast cancer cell line in cultureLipids.1995301139438614304Open DOISearch in Google Scholar
Fu J-Y, Tan DMY, Er HM, Chen YS, Nesaretnam K. Tumor-targeted niosome as novel carrier for intravenous administration of tocotrienol. Sriamornsak P, Limmatvapirat S, Piriyaprasarth S, editors. Asian Federation for Pharmaceutical Sciences (AFPS) 2015 Conference; 2015 Nov 25–27. Bangkok, Thailand. Asian J Pharm Sci. 2016; 11:79–80.FuJ-YTanDMYErHMChenYSNesaretnamK.Tumor-targeted niosome as novel carrier for intravenous administration of tocotrienolSriamornsakPLimmatvapiratSPiriyaprasarthSAsian Federation for Pharmaceutical Sciences (AFPS) 2015 Conference2015Nov 25–27Bangkok, ThailandAsian J Pharm Sci.2016117980Search in Google Scholar
Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C. Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res. 2015; 35:645–51.25667441VallianouNGEvangelopoulosASchizasNKazazisC.Potential anticancer properties and mechanisms of action of curcuminAnticancer Res.20153564551Search in Google Scholar
Xu YQ, Chen WR, Tsosie JK, Xie X, Li P, Wan J, et al. Niosome encapsulation of curcumin: characterization and cytotoxic effect on ovarian cancer cells. J Nanomater. 2016; 2016:6365295. 9p. 10.1155/2016/6365295.XuYQChenWRTsosieJKXieXLiPWanJNiosome encapsulation of curcumin: characterization and cytotoxic effect on ovarian cancer cellsJ Nanomater.201620166365295910.1155/2016/6365295Open DOISearch in Google Scholar
Sharma V, Anandhakumar S, Sasidharan M. Self-degrading niosomes for encapsulation of hydrophilic and hydrophobic drugs: an efficient carrier for cancer multi-drug delivery. Mater Sci Eng C Mater Biol Appl. 2015; 56:393–400.10.1016/j.msec.2015.06.04926249606SharmaVAnandhakumarSSasidharanM.Self-degrading niosomes for encapsulation of hydrophilic and hydrophobic drugs: an efficient carrier for cancer multi-drug deliveryMater Sci Eng C Mater Biol Appl.20155639340026249606Open DOISearch in Google Scholar
Antimalaria Coordinating Research Group. Antimalaria studies on qinghaosu. Chin Med J. 1979; 92:811–6.Antimalaria Coordinating Research GroupAntimalaria studies on qinghaosu. Chin Med J.1979928116Search in Google Scholar
Crespo-Ortiz MP, Wei MQ. Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. J Biomed Biotechnol. 2012; 2012:247597. 10.1155/2012/247597.22174561Crespo-OrtizMPWeiMQ.Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drugJ Biomed Biotechnol.2012201224759710.1155/2012/247597322829522174561Open DOISearch in Google Scholar
Li Q, Weina PJ, Milhous WK. Pharmacokinetic and pharmacodynamic profiles of rapid-acting artemisinins in the antimalarial therapy. Curr Drug Ther. 2007; 2:210–23.10.2174/157488507781695649LiQWeinaPJMilhousWK.Pharmacokinetic and pharmacodynamic profiles of rapid-acting artemisinins in the antimalarial therapyCurr Drug Ther.2007221023Open DOISearch in Google Scholar
Dwivedi A, Mazumder A, du Plessis L, du Preez JL, Haynes RK, du Plessis J. In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells. Nanomedicine. 2015; 11:2041–50.10.1016/j.nano.2015.07.01026282380DwivediAMazumderAdu PlessisLdu PreezJLHaynesRKdu PlessisJ.In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cellsNanomedicine.20151120415026282380Open DOISearch in Google Scholar
Cole MP, Jones CT, Todd ID. A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474. Br J Cancer. 1971; 25:270–75.10.1038/bjc.1971.335115829ColeMPJonesCTToddID.A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474Br J Cancer.1971252707520084535115829Open DOISearch in Google Scholar
Shaker DS, Shaker MA, Hanafy MS. Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes. Int J Pharm. 2015; 493:285–94.2620074810.1016/j.ijpharm.2015.07.041ShakerDSShakerMAHanafyMS.Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomesInt J Pharm.20154932859426200748Search in Google Scholar
Tila D, Yazdani-Arazi SN, Ghanbarzadeh S, Arami S, Pourmoazzen Z. pH-sensitive, polymer modified, plasma stable niosomes: promising carriers for anti-cancer drugs. EXCLI J. 2015; 14:21–32.26417350TilaDYazdani-AraziSNGhanbarzadehSAramiSPourmoazzenZ.pH-sensitive, polymer modified, plasma stable niosomes: promising carriers for anti-cancer drugsEXCLI J.2015142132Search in Google Scholar
Li M, Tang Z, Zhang Y, Lv S, Li Q, Chen X. Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis. Acta Biomater. 2015; 18:132–43.10.1016/j.actbio.2015.02.02225735801LiMTangZZhangYLvSLiQChenX.Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasisActa Biomater.2015181324325735801Open DOISearch in Google Scholar
Kanaani L, Javadi I, Ebrahimifar M, Ebrahimi shahmabadi H, Akbarzadeh Khiyavi A, Mehrdiba T. Effects of cisplatin-loaded niosomal nanoparticles on BT-20 human breast carcinoma cells. Asian Pac J Cancer Prev. 2017; 18:365–8.28345332KanaaniLJavadiIEbrahimifarMEbrahimi shahmabadiHAkbarzadeh KhiyaviAMehrdibaT.Effects of cisplatin-loaded niosomal nanoparticles on BT-20 human breast carcinoma cellsAsian Pac J Cancer Prev.2017183658Search in Google Scholar
Shilpa S, Srinivasan BP, Chauhan M. Niosomes as vesicular carriers for delivery of proteins and biologicals. Int J Drug Delivery. 2011; 3:14–24.10.5138/ijdd.2010.0975.0215.03050ShilpaSSrinivasanBPChauhanM.Niosomes as vesicular carriers for delivery of proteins and biologicalsInt J Drug Delivery.201131424Open DOISearch in Google Scholar
Terzano C, Allegra L, Alhaique F, Marianecci C, Carafa M. Non-phospholipid vesicles for pulmonary glucocorticoid delivery. Eur J Pharm Biopharm. 2005; 59:57–62.10.1016/j.ejpb.2004.06.01015567302TerzanoCAllegraLAlhaiqueFMarianecciCCarafaM.Non-phospholipid vesicles for pulmonary glucocorticoid deliveryEur J Pharm Biopharm.2005595762Open DOISearch in Google Scholar
Singh G, Dwivedi H, Saraf SK, Saraf SA. Niosomal delivery of isoniazid – development and characterization. Trop J Pharm Res. 2011; 10:203–10.SinghGDwivediHSarafSKSarafSA.Niosomal delivery of isoniazid – development and characterizationTrop J Pharm Res.2011102031010.4314/tjpr.v10i2.66564Search in Google Scholar
Jain CP, Vyas SP, Dixit VK. Niosomal system for delivery of rifampicin to lymphatics. Indian J Pharm Sci. 2006; 68:575–8.10.4103/0250-474X.29622JainCPVyasSPDixitVK.Niosomal system for delivery of rifampicin to lymphaticsIndian J Pharm Sci.2006685758Open DOISearch in Google Scholar
Kaur K, Gupta A, Narang RK, Murthy RSR. Novel drug delivery system: desired feat for tuberculosis. J Adv Pharm Tech Res. 2010; 1:145–63.KaurKGuptaANarangRKMurthyRSR.Novel drug delivery system: desired feat for tuberculosisJ Adv Pharm Tech Res.2010114563Search in Google Scholar
Mullaicharam AR, Murthy RSR. Lung accumulation of niosome-entrapped gentamicin sulfate follows intravenous and intratracheal administration in rats. J Drug Deliv Sci Tech. 2006; 16:109–13.10.1016/S1773-2247(06)50016-4MullaicharamARMurthyRSR.Lung accumulation of niosome-entrapped gentamicin sulfate follows intravenous and intratracheal administration in ratsJ Drug Deliv Sci Tech.20061610913Open DOISearch in Google Scholar
Muzzalupo R. Niosomes and proniosomes for enhanced skin delivery. In: Dragicevic N, Maibach H, editors. Percutaneous penetration enhancers chemical methods in penetration enhancement. Heidelberg: Springer; 2016. p. 147–60.MuzzalupoR.Niosomes and proniosomes for enhanced skin deliveryDragicevicNMaibachHPercutaneous penetration enhancers chemical methods in penetration enhancement.HeidelbergSpringer20161476010.1007/978-3-662-47862-2_10Search in Google Scholar
Fathalla D, Abdel-Mageed A, Abdel-Hamid F, Ahmed M. In-vitro and in-vivo evaluation of niosomal gel containing aceclofenac for sustained drug delivery. Int J Pharm Sci Res. 2014; 1:105. 10.15344/2394-1502/2014/105.FathallaDAbdel-MageedAAbdel-HamidFAhmedM.In-vitro and in-vivo evaluation of niosomal gel containing aceclofenac for sustained drug deliveryInt J Pharm Sci Res.2014110510.15344/2394-1502/2014/105Open DOISearch in Google Scholar
Kumbhar D, Wavikar P, Vavia P. Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity. AAPS PhamSciTech. 2013; 14:1072–82.10.1208/s12249-013-9986-5KumbharDWavikarPVaviaP.Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activityAAPS PhamSciTech.201314107282Open DOISearch in Google Scholar
Kamboj S, Saini V, Bala S, Sharma G. Formulation and characterization of drug loaded niosomal gel for anti-inflammatory activity. Int J Med Health Biomed Bioeng Pharm Eng. 2013; 7:877–81.KambojSSainiVBalaSSharmaG.Formulation and characterization of drug loaded niosomal gel for anti-inflammatory activityInt J Med Health Biomed Bioeng Pharm Eng.2013787781Search in Google Scholar
Shinde UA, Kanojiya SS. Serratiopeptidase niosomal gel with potential in topical delivery. J Pharm (Cario). 2014; 2014:9. 10.1155/2014/382959.ShindeUAKanojiyaSS.Serratiopeptidase niosomal gel with potential in topical deliveryJ Pharm (Cario).20142014910.1155/2014/382959Open DOISearch in Google Scholar
Fukai T, Satoh K, Nomura T, Sakagami H. Preliminary evaluation of antinephritis and radical scavenging activities of glabridin from Glycyrrhiza glabra. Fitoterapia. 2003; 74:624–9.10.1016/S0367-326X(03)00164-314630165FukaiTSatohKNomuraTSakagamiH.Preliminary evaluation of antinephritis and radical scavenging activities of glabridin from Glycyrrhiza glabraFitoterapia.2003746249Open DOISearch in Google Scholar
Morteza-Semnani K, Saeedi M, Shahnavaz B. Comparison of antioxidant activity of extract from roots of licorice (Glycyrrhiza glabra L.) to commercial antioxidants in 2% hydroquinone cream. J Cosmet Sci. 2003; 54:551–8.14730371Morteza-SemnaniKSaeediMShahnavazB.Comparison of antioxidant activity of extract from roots of licorice (Glycyrrhiza glabra L.) to commercial antioxidants in 2% hydroquinone creamJ Cosmet Sci.2003545518Search in Google Scholar
Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release. 2005; 106:99–110.1593550510.1016/j.jconrel.2005.04.007PaolinoDLucaniaGMardenteDAlhaiqueFFrestaM.Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteersJ Control Release.20051069911015935505Search in Google Scholar
Matsui S, Matsumoto H, Sonoda Y, Ando K, Aizu-Yokota E, Sato T, et al. Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line. Int Immunopharmacol. 2004; 4:1633–44.10.1016/j.intimp.2004.07.023MatsuiSMatsumotoHSonodaYAndoKAizu-YokotaESatoTGlycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell lineInt Immunopharmacol.20044163344Open DOISearch in Google Scholar
Marianecci C, Rinaldi F, Mastriota M, Pieretti S, Trapasso E, Paolino D, et al. Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine models. J Control Release. 2012; 164:17–25.10.1016/j.jconrel.2012.09.01823041542MarianecciCRinaldiFMastriotaMPierettiSTrapassoEPaolinoDAnti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine modelsJ Control Release.20121641725Open DOISearch in Google Scholar
Priprem A, Janpim K, Nualkaew S, Mahakunakorn P. Topical niosome gel of Zingiber cassumunar Roxb. extract for anti-inflammatory activity enhanced skin permeation and stability of compound D. AAPS PhamSciTech. 2016; 17:631–9.10.1208/s12249-015-0376-zPripremAJanpimKNualkaewSMahakunakornP.Topical niosome gel of Zingiber cassumunar Roxb. extract for anti-inflammatory activity enhanced skin permeation and stability of compound DAAPS PhamSciTech.2016176319Open DOISearch in Google Scholar
Leelarungrayub J, Manorsoi J, Manorsoi A. Anti-inflammatory activity of niosomes entrapped with Plai oil (Zingiber cassumunar Roxb.) by therapeutic ultrasound in a rat model. Int J Nanomedicine. 2017; 12:2469–76.10.2147/IJN.S129131LeelarungrayubJManorsoiJManorsoiA.Anti-inflammatory activity of niosomes entrapped with Plai oil (Zingiber cassumunar Roxb.) by therapeutic ultrasound in a rat modelInt J Nanomedicine.201712246976Open DOISearch in Google Scholar
Jang M, Cai L, Udeani GO. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997; 275:218–20.898501610.1126/science.275.5297.218JangMCaiLUdeaniGO.Cancer chemopreventive activity of resveratrol, a natural product derived from grapesScience.199727521820Search in Google Scholar
Tome-Carneiro J, Larrosa M, Gonzalez-Sarrias A, Tomás-Barberán FA, García-Conesa MT, Espín JC. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Cur Pharma Des. 2013; 19:6064–93.10.2174/13816128113199990407Tome-CarneiroJLarrosaMGonzalez-SarriasATomás-BarberánFAGarcía-ConesaMTEspínJC.Resveratrol and clinical trials: the crossroad from in vitro studies to human evidenceCur Pharma Des.201319606493Open DOISearch in Google Scholar
Davidov-Pardo G, McClements DJ. Resveratrol encapsulation: designing delivery systems to overcome solubility, stability and bioavailability issues. Trends Food Sci Technol. 2014; 38:88–103.10.1016/j.tifs.2014.05.003Davidov-PardoGMcClementsDJ.Resveratrol encapsulation: designing delivery systems to overcome solubility, stability and bioavailability issuesTrends Food Sci Technol.20143888103Open DOISearch in Google Scholar
Negi P, Aggarwal M, Sharma G, Rathore C, Sharma G, Singh B, et al. Niosome-based hydrogel of resveratrol for topical applications: an effective therapy for pain related disorder(s). Biomed Pharmacother. 2017; 88:480–87.2812667310.1016/j.biopha.2017.01.083NegiPAggarwalMSharmaGRathoreCSharmaGSinghBNiosome-based hydrogel of resveratrol for topical applications: an effective therapy for pain related disorder(s)Biomed Pharmacother.20178848087Search in Google Scholar
van Sorge AA, Wijnen PH, van Delft JL, Coré-Bodelier VM, van Haeringen NJ. Flurbiprofen, S(+), eyedrops: formulation, enantiomeric assay, shelf life and pharmacology. Pharm World Sci. 1999; 21:91–5.1038023710.1023/A:1008609513880van SorgeAAWijnenPHvan DelftJLCoré-BodelierVMvan HaeringenNJ.Flurbiprofen, S(+), eyedrops: formulation, enantiomeric assay, shelf life and pharmacologyPharm World Sci.199921915Search in Google Scholar
Lang JC. Ocular drug delivery conventional ocular formulations. Adv Drug Delivery Rev. 1995; 16:39–43.10.1016/0169-409X(95)00012-VLangJC.Ocular drug delivery conventional ocular formulationsAdv Drug Delivery Rev.1995163943Open DOISearch in Google Scholar
Zhang W, Prausnitz MR, Edwards A. Model of transient drug diffusion across cornea. J Control Release. 2004; 99:241–58.1538063410.1016/j.jconrel.2004.07.001ZhangWPrausnitzMREdwardsA.Model of transient drug diffusion across corneaJ Control Release.20049924158Search in Google Scholar
El-Sayed MM, Hussein AK, Sarhan HA, Mansour HF. Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor. Drug Dev Ind Pharm. 2017; 43:902–10.2797731110.1080/03639045.2016.1272120El-SayedMMHusseinAKSarhanHAMansourHF.Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humorDrug Dev Ind Pharm.20174390210Search in Google Scholar
Wagh VD, Deshmukh OJ. Itraconazole niosomes drug delivery system and its antimycotic activity against Candida albicans. ISRN Pharm. 2012; 2012:653465.23378932WaghVDDeshmukhOJ.Itraconazole niosomes drug delivery system and its antimycotic activity against Candida albicansISRN Pharm.2012201265346510.5402/2012/653465Search in Google Scholar
Alam M, Zubair S, Farazuddin M, Ahmad E, Khan A, Zia Q, et al. Development, characterization and efficacy of niosomal diallyl disulfide in treatment of disseminated murine candidiasis. Nanomedicine. 2013; 9:247–56.10.1016/j.nano.2012.07.00422858760AlamMZubairSFarazuddinMAhmadEKhanAZiaQDevelopment, characterization and efficacy of niosomal diallyl disulfide in treatment of disseminated murine candidiasisNanomedicine.2013924756Open DOISearch in Google Scholar
Fetih G. Fluconazole-loaded niosomal gels as a topical ocular drug delivery system for corneal fungal infections. J Drug Deliv Sci Technol. 2016; 35:8–15.10.1016/j.jddst.2016.06.002FetihG.Fluconazole-loaded niosomal gels as a topical ocular drug delivery system for corneal fungal infectionsJ Drug Deliv Sci Technol.201635815Open DOISearch in Google Scholar
Gupta A, Kar HK. Antidermatophytic activity of miconazole nanoformulation against Trichophyton rubrum. Asian Pac J Trop Dis. 2015; 5:707–10.10.1016/S2222-1808(15)60917-3GuptaAKarHK.Antidermatophytic activity of miconazole nanoformulation against Trichophyton rubrumAsian Pac J Trop Dis.2015570710Open DOISearch in Google Scholar
de Arauz LJ, Jozala AF, Mazzola PG, Penna TCV. Nisin biotechnological production and application: a review. Trends Food Sci Technol. 2009; 20:146–54.10.1016/j.tifs.2009.01.056de ArauzLJJozalaAFMazzolaPGPennaTCV.Nisin biotechnological production and application: a reviewTrends Food Sci Technol.20092014654Open DOISearch in Google Scholar
Boziaris IS, Adams MR. Effect of chelators and nisin produced in situ on inhibition and inactivation of Gram negatives. Int J Food Microbiol. 1999; 53:105–13.10.1016/S0168-1605(99)00139-710634702BoziarisISAdamsMR.Effect of chelators and nisin produced in situ on inhibition and inactivation of Gram negativesInt J Food Microbiol.19995310513Open DOISearch in Google Scholar
Kopermsub P, Mayen V, Warin C. Potential use of niosomes for encapsulation of nisin and EDTA and their antibacterial activity enhancement. Food Res Int. 2011; 44:605–12.10.1016/j.foodres.2010.12.011KopermsubPMayenVWarinC.Potential use of niosomes for encapsulation of nisin and EDTA and their antibacterial activity enhancementFood Res Int.20114460512Open DOISearch in Google Scholar
Kellner R, Jung G, Hörner T, Zähner H, Schnell N, Entian KD, et al. Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur J Biochem. 1988; 177:53–9.10.1111/j.1432-1033.1988.tb14344.x3181159KellnerRJungGHörnerTZähnerHSchnellNEntianKDGallidermin: a new lanthionine-containing polypeptide antibioticEur J Biochem.19881775393181159Open DOISearch in Google Scholar
Manosroi A, Khanrin P, Lohcharoenkal W, Werner RG, Götz F, Manosroi W, et al. Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm. 2010; 392:304–10.10.1016/j.ijpharm.2010.03.06420381599ManosroiAKhanrinPLohcharoenkalWWernerRGGötzFManosroiWTransdermal absorption enhancement through rat skin of gallidermin loaded in niosomesInt J Pharm.201039230410Open DOISearch in Google Scholar
Burdock G. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem Toxicol. 1998; 36:347–63.10.1016/S0278-6915(97)00145-29651052BurdockG.Review of the biological properties and toxicity of bee propolis (propolis)Food Chem Toxicol.19983634763Open DOISearch in Google Scholar
Patel J, Ketkar S, Patil S, Fearnley J, Mahadik KR, Paradkar AR. Potentiating antimicrobial efficacy of propolis through niosomal-based system for administration. Integr Med Res. 2015; 4:94–101.10.1016/j.imr.2014.10.00428664114PatelJKetkarSPatilSFearnleyJMahadikKRParadkarAR.Potentiating antimicrobial efficacy of propolis through niosomal-based system for administrationIntegr Med Res.2015494101548179828664114Open DOISearch in Google Scholar
Zubairu Y, Negi LM, Iqbal Z, Talegaonkar S. Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: In-vitro and ex-vivo investigations. Asian J Pharm Sci. 2015; 10:322–30.10.1016/j.ajps.2015.02.001ZubairuYNegiLMIqbalZTalegaonkarS.Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: In-vitro and ex-vivo investigationsAsian J Pharm Sci.20151032230Open DOISearch in Google Scholar
Sohrabi S, Haeri A, Mahboubi A, Mortazavi A, Dadashzadeh S. Chitosan gel-embedded moxifloxacin niosomes: an efficient antimicrobial hybrid system for burn infection. Int J Biol Macromol. 2016; 85:625–33.10.1016/j.ijbiomac.2016.01.01326794314SohrabiSHaeriAMahboubiAMortazaviADadashzadehS.Chitosan gel-embedded moxifloxacin niosomes: an efficient antimicrobial hybrid system for burn infectionInt J Biol Macromol.2016856253326794314Open DOISearch in Google Scholar
Wagner VE, Iglewski BH. Pseudomonas aeruginosa biofilms in CF infection. Clin Rev Allergy Immunol. 2008; 35:124–34.10.1007/s12016-008-8079-918509765WagnerVEIglewskiBH.Pseudomonas aeruginosa biofilms in CF infectionClin Rev Allergy Immunol.2008351243418509765Open DOISearch in Google Scholar
Mahdiun F, Mansouri S, Khazaeli P, Mirzaei R. The effect of tobramycin incorporated with bismuth-ethanedithiol loaded on niosomes on the quorum sensing and biofilm formation of Pseudomonas aeruginosa. Microb Pathog. 2017; 107:129–35.10.1016/j.micpath.2017.03.01428323149MahdiunFMansouriSKhazaeliPMirzaeiR.The effect of tobramycin incorporated with bismuth-ethanedithiol loaded on niosomes on the quorum sensing and biofilm formation of Pseudomonas aeruginosaMicrob Pathog.20171071293528323149Open DOISearch in Google Scholar
Borowska K, Wolowiec S, Rubaj A, Glowniak K, Sieniawska E, Radej S. Effect of polyamidoamine dendrimer G3 and G4 on skin permeation of 8-methoxypsoralene-In vivo study. Int J Pharm. 2012; 426:280–83.10.1016/j.ijpharm.2012.01.041BorowskaKWolowiecSRubajAGlowniakKSieniawskaERadejS.Effect of polyamidoamine dendrimer G3 and G4 on skin permeation of 8-methoxypsoralene-In vivo studyInt J Pharm.20124262808322310461Open DOISearch in Google Scholar
Kassem AA, Abd El-Alim SH, Asfour MH. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: formulation development, in vitro and in vivo evaluation of skin deposition. Int J Pharm. 2017; 517:256–68.2795619410.1016/j.ijpharm.2016.12.018KassemAAAbd El-AlimSHAsfourMH.Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: formulation development, in vitro and in vivo evaluation of skin depositionInt J Pharm.20175172566827956194Search in Google Scholar
Jacob S, Nair AB, Al-Dhubiab BE. Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition. J Liposome Res. 2017; 27:283–92.10.1080/08982104.2016.122489727558522JacobSNairABAl-DhubiabBE.Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal depositionJ Liposome Res.2017272839227558522Open DOISearch in Google Scholar
Cortesi R, Esposito E. Acyclovir delivery systems. Expert Opin Drug Deliv. 2008; 5:1217–30.10.1517/1742524080245034018976132CortesiREspositoE.Acyclovir delivery systemsExpert Opin Drug Deliv.2008512173018976132Open DOISearch in Google Scholar
Mashal M, Attia N, Puras G, Martínez-Navarrete G, Fernández E, Pedraz JL. Retinal gene delivery enhancement by lycopene incorporation into cationic niosomes based on DOTMA and polysorbate 60. J Control Release. 2017; 254:55–64.2834780710.1016/j.jconrel.2017.03.386MashalMAttiaNPurasGMartínez-NavarreteGFernándezEPedrazJL.Retinal gene delivery enhancement by lycopene incorporation into cationic niosomes based on DOTMA and polysorbate 60J Control Release.2017254556428347807Search in Google Scholar
Opanasopit P, Leksantikul L, Niyomtham N, Rojanarata T, Ngawhirunpat T, Yingyongnarongkul BE. Cationic niosomes an effective gene carrier composed of novel spermine-derivative cationic lipids: effect of central core structures. Pharm Dev Technol. 2017; 22:350–59.10.3109/10837450.2015.112592526708923OpanasopitPLeksantikulLNiyomthamNRojanarataTNgawhirunpatTYingyongnarongkulBE.Cationic niosomes an effective gene carrier composed of novel spermine-derivative cationic lipids: effect of central core structuresPharm Dev Technol.2017223505926708923Open DOISearch in Google Scholar
Hashemi Dehaghi M, Haeri A, Keshvari H, Abbasian Z, Dadashzadeh S. Dorzolamide loaded niosomal vesicles: comparison of passive and remote loading methods. Iran J Pharm Res. 2017; 16:413–22.28979296Hashemi DehaghiMHaeriAKeshvariHAbbasianZDadashzadehS.Dorzolamide loaded niosomal vesicles: comparison of passive and remote loading methodsIran J Pharm Res.20171641322Search in Google Scholar
Hsu CY, Chen CH, Aljuffali IA, Dai YS, Fang JY. Nanovesicle delivery to the liver via retinol binding protein and platelet-derived growth factor receptors: how targeting ligands affect biodistribution. Nanomedicine (Lond). 2017; 12:317–31.10.2217/nnm-2016-031928078954HsuCYChenCHAljuffaliIADaiYSFangJY.Nanovesicle delivery to the liver via retinol binding protein and platelet-derived growth factor receptors: how targeting ligands affect biodistributionNanomedicine (Lond).2017123173128078954Open DOISearch in Google Scholar
Moghassemi S, Hadjizadeh A, Hakamivala A, Omidfar K. Growth factor-loaded nano-niosomal gel formulation and characterization. AAPS PharmSciTech. 2017; 18:34–41.10.1208/s12249-016-0579-y27502406MoghassemiSHadjizadehAHakamivalaAOmidfarK.Growth factor-loaded nano-niosomal gel formulation and characterizationAAPS PharmSciTech.201718344127502406Open DOISearch in Google Scholar
Moghassemi S, Hadjizadeh A, Omidfar K. Formulation and characterization of bovine serum albumin-loaded niosome. AAPS PharmSciTech. 2017; 18:27–33.10.1208/s12249-016-0487-126817764MoghassemiSHadjizadehAOmidfarK.Formulation and characterization of bovine serum albumin-loaded niosomeAAPS PharmSciTech.201718273326817764Open DOISearch in Google Scholar
